The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) EV/EBITDA
As of 5 November 2026, The Chemours Company (CC) trades at a EV/EBITDA of 23.2×. Over the past ten years it has ranged from 0.0× (June 2024) to 113× (December 2023); the current reading is higher than 80% of that period. That is above the Specialty Chemicals industry median of 12.9× and above the Basic Materials sector median of 9.2×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 18.3× | 109.19% |
| FY2024 | 8.7× | (90.85%) |
| FY2023 | 95.4× | 1,303.07% |
| FY2022 | 6.8× | (13.04%) |
| FY2021 | 7.8× | (22.31%) |
| FY2020 | 10.1× | 8.44% |
| FY2019 | 9.3× | 76.62% |
| FY2018 | 5.3× | (45.08%) |
| FY2017 | 9.6× | (69.67%) |
| FY2016 | 31.5× | (1.07%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 23.7× | (18.35%) |
| Jun 2026 | 29.1× | 5.75% |
| Mar 2026 | 27.5× | 50.46% |
| Dec 2025 | 18.3× | 11.07% |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| STDN Standard Nuclear Inc compare | n/m |
| FUL H. B. Fuller Company compare | 8.4× |
| IOSP Innospec Inc. compare | 9.3× |
| KWR Quaker Houghton compare | 13.1× |
| NGVT Ingevity Corporation compare | 13.2× |
| SCL Stepan Company compare | 14.6× |
| CC The Chemours Company | 23.2× |
| WDFC WD-40 Company compare | 25.7× |
| MTX Minerals Technologies Inc. compare | 34.6× |
| Specialty Chemicals industry median | 12.9× |
| Basic Materials sector median | 9.2× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement